Skip to content

Goodwill at other companies

PBH
Prestige Consumer HealthcarePBH
$581.11M+10.2%
Bausch + Lomb logo
Bausch + LombBLCO
$4.74B+3.7%
Johnson & Johnson logo
Johnson & JohnsonJNJ
$48.56B+9.2%
AbbVie logo
AbbVieABBV
$35.57B+0.8%
Organon logo
OrganonOGN
$4.15B-11.3%
HRO
HarrowHROW
$332K0.0%

Segments

By segment

See full
Bausch + Lomb$5.48B+3.2%
Salix$1.73B-45.1%
Diversified$1.58B-9.3%
International$880M+6.2%
Solta Medical$137M+19.1%

Other financials

Income statement

See full
Revenue$2.5B+11.7%
Operating income-$950.0M-444%
Net income-$1.4B-2,353%
EPS (diluted)-$3.82-2,287%

Balance sheet

See full
Cash & equivalents$1.3B+13.4%
Total debt$20.8B-3.5%
Total equity-$2.1B-74.0%
Total assets$24.5B-7.3%

Cash flow

See full
Operating cash flow$230.0M+9.0%
CapEx$109.0M-5.2%
Free cash flow$121.0M+26.0%

Valuation

See full
Market cap$1.86B-15.9%

Profitability

See full
Gross margin71.4%
Operating margin5.6%-10.3pp
Net margin-1.9%-0.9pp
FCF margin9.8%-2.8pp

Returns & leverage

See full
Return on equity-70.1%
Debt / equity45.2×
Current ratio1.3×0.0×

Where this comes from

Reported directly by Bausch Health Companies in its filing.

Tagged under the XBRL concept us-gaap:Goodwill.

The official record: Bausch Health Companies’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Bausch Health Companies's goodwill.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Bausch Health Companies's goodwill?
Bausch Health Companies (BHC) reported goodwill of $9.81B in Q1 2026.
How has Bausch Health Companies's goodwill changed year-over-year?
Bausch Health Companies's goodwill decreased by 12.1% year-over-year, from $11.15B to $9.81B.
What is the long-term trend for Bausch Health Companies's goodwill?
Over 5 years (2020 to 2025), Bausch Health Companies's goodwill has grown at a -2.9% compound annual growth rate (CAGR), from $13.04B to $11.27B.
What does goodwill mean?
The excess of acquisition cost over the fair value of net identifiable assets acquired — representing brand value, customer relationships, and synergies from past M&A.